help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Downing, J. R.
Right arrow Articles by Shapiro, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Downing, J. R.
Right arrow Articles by Shapiro, D. N.

American Journal of Pathology, Vol 143, 1294-1300, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction

JR Downing, DR Head, DM Parham, EC Douglass, MG Hulshof, MP Link, TA Motroni, HE Grier, AM Curcio-Brint and DN Shapiro
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.

Ewing's sarcoma and the related primitive neuroectodermal tumor (PNET) share a unique and specific t(11;22)(q24;q12) chromosomal translocation. The breakpoints have recently been cloned and shown to involve the EWS gene on chromosome 22 and the FLI-1 gene on chromosome 11. Translocation results in the fusion of these genes on the der(22) chromosome, resulting in the production of a novel chimeric EWS/FLI-1 message. Using oligonucleotide primers derived from EWS and FLI-1 complementary DNAs, we were able to amplify a specific fusion transcript from 18 of 18 cases containing t(11;22) and 10 of 14 cases of Ewing's sarcoma/PNET that had unsuccessful cytogenetics. No EWS/FLI- 1 fusion transcripts were detected in five cell lines derived from cases of pediatric sarcomas having a histological diagnosis other than Ewing's sarcoma/PNET. The sensitivity and specificity of this PCR analysis demonstrates the usefulness of this approach for the primary diagnosis of t(11;22)-containing Ewing's sarcoma/PNET and for the detection of metastatic or residual disease.


This article has been cited by other articles:


Home page
JCOHome page
A. Ohali, S. Avigad, I.J. Cohen, I. Meller, Y. Kollender, J. Issakov, I. Gelernter, Y. Goshen, I. Yaniv, and R. Zaizov
Association Between Telomerase Activity and Outcome in Patients With Nonmetastatic Ewing Family of Tumors
J. Clin. Oncol., October 15, 2003; 21(20): 3836 - 3843.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
R. G. Levine, C. M. Bono, M. Hameed, M. Blacksin, A. C. Pavlick, C. Cathcart, and J. Benevenia
Ewing Sarcoma in an Octogenarian : A Case Report
J. Bone Joint Surg. Am., March 1, 2002; 84(3): 445 - 448.
[Full Text]


Home page
INT J SURG PATHOLHome page
E. de Alava and J. Pardo
Ewing Tumor: Tumor Biology and Clinical Applications
International Journal of Surgical Pathology, January 1, 2001; 9(1): 7 - 17.
[Abstract] [PDF]


Home page
PediatricsHome page
J. E. Rubnitz and W. M. Crist
Molecular Genetics of Childhood Cancer: Implications for Pathogenesis, Diagnosis, and Treatment
Pediatrics, July 1, 1997; 100(1): 101 - 108.
[Full Text] [PDF]


Home page
NEJMHome page
C. S. Kretschmar
Ewing's Sarcoma and the "Peanut" Tumors
N. Engl. J. Med., August 4, 1994; 331(5): 325 - 327.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.